Aims and scope
Allergy, Asthma & Clinical Immunology (AACI), the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that encompasses all aspects of diagnosis, epidemiology, prevention and treatment of allergic and immunologic disease.
AACI reports on basic research and clinically applied studies in the following areas and other related topics: asthma and occupational lung disease, rhinoconjunctivitis and rhinosinusitis, drug hypersensitivity, allergic skin diseases, urticaria and angioedema, venom hypersensitivity, anaphylaxis and food allergy, immunotherapy, immune modulators and biologics, immune deficiency and autoimmunity, T cell and B cell functions, regulatory T cells, natural killer cells, mast cell and eosinophil functions, complement abnormalities.
Richard Warrington, University of Manitoba, Canada
Harold Kim, University of Western Ontario & McMaster University, Canada
Rajesh Kumar, Ann & Robert H. Lurie Children's Memorial Hospital, USA
Jean Marshall, Dalhousie University, Canada
Wade Watson, Dalhousie University, Canada
About the CSACI
AACI is the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI). The CSACI is the largest national professional medical specialty organization in Canada representing allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic diseases.
The CSACI was founded in 1945 to fulfill the following goals: improving the standards of teaching and the practice of allergy and clinical immunology; fostering co-operation between those engaged in the study and practice of allergy and clinical immunology; encourage research in the field of allergy and clinical immunology.
The CSACI represents over 475 (Canadian and international) members who are from all parts of the country including rural areas, cities, community hospitals and academic university teaching centres. The CSACI remains committed to supporting allergists and clinical immunologists in maintaining the pre-eminence of both research and education in Canada. Moving forward, the CSACI will support these aims to ensure that high quality health care is available to all our patients throughout our communities.
The official journal of CSACI
2017 Journal Metrics
68 days to first decision for reviewed manuscripts only
63 days to first decision for all manuscripts
145 days from submission to acceptance
15 days from acceptance to publication
604 Altmetric Mentions